ERK signalling: a master regulator of cell behaviour, life and fate
H Lavoie, J Gagnon, M Therrien - Nature reviews Molecular cell biology, 2020 - nature.com
The proteins extracellular signal-regulated kinase 1 (ERK1) and ERK2 are the downstream
components of a phosphorelay pathway that conveys growth and mitogenic signals largely …
components of a phosphorelay pathway that conveys growth and mitogenic signals largely …
Phenotype plasticity as enabler of melanoma progression and therapy resistance
I Arozarena, C Wellbrock - Nature Reviews Cancer, 2019 - nature.com
Malignant melanoma is notorious for its inter-and intratumour heterogeneity, based on
transcriptionally distinct melanoma cell phenotypes. It is thought that these distinct …
transcriptionally distinct melanoma cell phenotypes. It is thought that these distinct …
Stromal changes in the aged lung induce an emergence from melanoma dormancy
Disseminated cancer cells from primary tumours can seed in distal tissues, but may take
several years to form overt metastases, a phenomenon that is termed tumour dormancy …
several years to form overt metastases, a phenomenon that is termed tumour dormancy …
[HTML][HTML] Toward minimal residual disease-directed therapy in melanoma
Many patients with advanced cancers achieve dramatic responses to a panoply of
therapeutics yet retain minimal residual disease (MRD), which ultimately results in relapse …
therapeutics yet retain minimal residual disease (MRD), which ultimately results in relapse …
MITF—the first 25 years
CR Goding, H Arnheiter - Genes & development, 2019 - genesdev.cshlp.org
All transcription factors are equal, but some are more equal than others. In the 25 yr since
the gene encoding the microphthalmia-associated transcription factor (MITF) was first …
the gene encoding the microphthalmia-associated transcription factor (MITF) was first …
[HTML][HTML] WNT signaling in melanoma
A Gajos-Michniewicz, M Czyz - International journal of molecular sciences, 2020 - mdpi.com
WNT-signaling controls important cellular processes throughout embryonic development
and adult life, so any deregulation of this signaling can result in a wide range of pathologies …
and adult life, so any deregulation of this signaling can result in a wide range of pathologies …
Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilities
R Rabbie, P Ferguson, C Molina‐Aguilar… - The Journal of …, 2019 - Wiley Online Library
Melanoma is characterised by its ability to metastasise at early stages of tumour
development. Current clinico‐pathologic staging based on the American Joint Committee on …
development. Current clinico‐pathologic staging based on the American Joint Committee on …
[HTML][HTML] The master role of microphthalmia-associated transcription factor in melanocyte and melanoma biology
A Kawakami, DE Fisher - Laboratory investigation, 2017 - Elsevier
Certain transcription factors have vital roles in lineage development, including specification
of cell types and control of differentiation. Microphthalmia-associated transcription factor …
of cell types and control of differentiation. Microphthalmia-associated transcription factor …
[HTML][HTML] Inhibiting drivers of non-mutational drug tolerance is a salvage strategy for targeted melanoma therapy
Once melanomas have progressed with acquired resistance to mitogen-activated protein
kinase (MAPK)-targeted therapy, mutational heterogeneity presents a major challenge. We …
kinase (MAPK)-targeted therapy, mutational heterogeneity presents a major challenge. We …
[HTML][HTML] MITF in normal melanocytes, cutaneous and uveal melanoma: a delicate balance
MC Gelmi, LE Houtzagers, T Strub, I Krossa… - International journal of …, 2022 - mdpi.com
Microphthalmia-associated transcription factor (MITF) is an important regulator of
melanogenesis and melanocyte development. Although it has been studied extensively in …
melanogenesis and melanocyte development. Although it has been studied extensively in …